Skip to main content

Table 1 Demographic and clinical characteristics of the study cohort with or without episodes of Incident Parkinson’s Disease

From: Gout and the risk of Parkinson’s disease in older adults: a study of U.S. Medicare data

 

Entire cohort

Parkinson’s Disease during the follow-up

No

Yes

Total people, N

1,725,833a

1,703,197

22,636

Age, mean (SD)

75.3 (7.6)

75.3 (7.6)

76.5 (6.7)

Gender, N (%)

 Male

730,850 (42.3%)

719,315 (42.2%)

11,535 (51.0%)

 Female

994,983 (57.7%)

983,882 (57.8%)

11,101 (49.0%)

Race/Ethnicity, N (%)

 White

1,486,250 (86.1%)

1,466,103 (86.1%)

20,147 (89.0%)

 Black

142,086 (8.2%)

140,801 (8.3%)

1285 (5.7%)

 Other/unknown

97,497 (5.6%)

96,293 (5.7%)

1204 (5.3%)

Charlson

 0

909,974 (52.7%)

901,096 (52.9%)

8878 (39.2%)

 1

173,518 (10.1%)

170,653 (10.0%)

2865 (12.7%)

  ≥ 2

642,341 (37.2%)

631,448 (37.1%)

10,893 (48.1%)

Charlson-Romano comorbidity score, mean (SD)

1.60 (2.39)

1.59 (2.39)

2.10 (2.51)

Charlson-Romano comorbidities

 Myocardial Infarction

68,537 (4.0%)

67,469 (4.0%)

1068 (4.7%)

 Heart Failure

202,196 (11.7%)

198,932 (11.7%)

3264 (14.4%)

 Peripheral vascular disease

167,945 (9.7%)

164,946 (9.7%)

2999 (13.2%)

 Cerebrovascular disease

167,247 (9.7%)

163,696 (9.6%)

3551 (15.7%)

 Dementia

75,936 (4.4%)

73,689 (4.3%)

2247 (9.9%)

 Chronic pulmonary disease

269,751 (15.6%)

265,719 (15.6%)

4032 (17.8%)

 Connective tissue disease

47,999 (2.8%)

47,267 (2.8%)

732 (3.2%)

 Peptic ulcer disease

32,624 (1.9%)

32,018 (1.9%)

606 (2.7%)

 Mild liver disease

8506 (0.49%)

8403 (0.49%)

103 (0.46%)

 Diabetes

319,089 (18.5%)

313,715 (18.4%)

5374 (23.7%)

 Diabetes with end organ damage

94,120 (5.5%)

92,363 (5.4%)

1757 (7.8%)

 Hemiplegia

14,118 (0.82%)

13,833 (0.81%)

285 (1.3%)

 Renal failure/disease

59,340 (3.4%)

58,427 (3.4%)

913 (4.0%)

 Any tumor, leukemia or lymphoma

173,685 (10.1%)

170,940 (10.0%)

2745 (12.1%)

 Moderate/severe liver disease

1992 (0.12%)

1959 (0.12%)

33 (0.15%)

 Metastatic cancer

17,950 (1.0%)

17,796 (1.0%)

154 (0.68%)

 AIDS

547 (0.03%)

541 (0.03%)

6 (0.03%)

Hypertension

833,128 (48.3%)

819,889 (48.1%)

13,239 (58.5%)

Hyperlipidemia

601,188 (34.8%)

591,507 (34.7%)

9681 (42.8%)

Coronary artery disease

302,982 (17.6%)

297,391 (17.5%)

5591 (24.7%)

  1. a met eligibility criteria and did not have PD in the baseline 365-day period; SD, standard deviation; Bold represents statistically significant differences with p <0.001